x ray cystic fibrosis
Biotech

Boehringer axes gene therapy after seeing cystic fibrosis data

Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis after terminating a phase 1/2 trial.
Gabrielle Masson Feb 17, 2026 1:12pm
Tokyo stock exchange

Cell therapy biotech could end Tokyo IPO drought with $92M offer

Feb 17, 2026 11:06am
Glowing puzzle piece fitting into puzzle

Gilead pens $1.5B Genhouse deal for synthetic lethal therapy

Feb 16, 2026 2:00pm
wheel

Biohaven CEO calls recent FDA decisions 'a systemic problem'

Feb 13, 2026 4:14pm
Sanofi headquarters Sanofi

Sanofi points to long-term efficacy of Teva-partnered IBD drug

Feb 17, 2026 8:05am
x

Fierce Biotech Layoff Tracker 2026: Concerto, Seres & more

Feb 17, 2026 3:45pm
More News

RoukenBio, AVS Bio partner for predictable antibody development

Feb 17, 2026 3:45pm

Cyrano noses toward pivotal trial after midphase smell loss win

Feb 17, 2026 10:15am

Compass guides psychedelic to 2nd pivotal depression win

Feb 17, 2026 8:39am

PitchBook expects disciplined biopharma VC recovery in 2026

Feb 16, 2026 12:01am